The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer Pekka Uotila Perspectives 17 November 1996 Pages: 1 - 9
T cell receptor V&; and V&; gene usage by tumour-infiltrating lymphocytes in oral squamous cell carcinoma Takefumi MouriS. NakamuraKikuo Nomoto ORIGINAL ARTICLE 17 November 1996 Pages: 10 - 18
Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells Marina CardilloBoris YankelevichR. Lupu ORIGINAL ARTICLE 17 November 1996 Pages: 19 - 25
Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10 Larry M. RoseA. H. GunasekeraC. F. Meares ORIGINAL ARTICLE 17 November 1996 Pages: 26 - 30
The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells S. KurosawaM. HaradaKikuo Nomoto ORIGINAL ARTICLE 17 November 1996 Pages: 31 - 38
Retention and processing of the monoclonal anti-prostate E4 antibody after binding to prostatic adenocarcinoma DU 145 cells Magnus EssandP. LögdahlJ. Carlsson ORIGINAL ARTICLE 17 November 1996 Pages: 39 - 43
Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains M. R. L. KrulEdwin J. TijhaarWillem Den Otter ORIGINAL ARTICLE 17 November 1996 Pages: 44 - 48
Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor Vβ usage by tumor-infiltrating lymphocytes Lisa A. DeBruyneAlfred E. ChangD. Keith Bishop ORIGINAL ARTICLE 17 November 1996 Pages: 49 - 58
Diabetes mellitus induced by low-dose interleukin-2 Neeta SoniN. J. MeropolMichael A. Caligiuri ORIGINAL ARTICLE 17 November 1996 Pages: 59 - 62
